Cardiol Therapeutics Inc. Files 6-K, Incorporates Exhibit
Ticker: CRDL · Form: 6-K · Filed: Oct 9, 2024 · CIK: 1702123
Sentiment: neutral
Topics: sec-filing, registration-statement, administrative
Related Tickers: CRDL
TL;DR
Cardiol Therapeutics (CRDL) filed a 6-K, incorporating an exhibit into its F-10 registration. No new material info, just an update.
AI Summary
Cardiol Therapeutics Inc. filed a Form 6-K on October 9, 2024, to incorporate Exhibit 99.1 by reference into its existing Registration Statement on Form F-10 (File No. 333-280713). This filing does not contain new financial information but serves to update or supplement the previously filed registration statement.
Why It Matters
This filing indicates an administrative update to an existing registration statement, potentially related to ongoing capital-raising or securities offerings, but doesn't introduce new operational or financial data.
Risk Assessment
Risk Level: low — The filing is administrative and incorporates an existing exhibit into a registration statement, posing no immediate new risks.
Key Numbers
- 001-40712 — SEC File Number (Identifies the company's filing with the SEC.)
- 333-280713 — Registration Statement File Number (References the specific registration statement being supplemented.)
Key Players & Entities
- Cardiol Therapeutics Inc. (company) — Registrant
- 001-40712 (other) — SEC File Number
- 333-280713 (other) — Registration Statement File Number
- October 9, 2024 (date) — Filing Date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to incorporate Exhibit 99.1 by reference into Cardiol Therapeutics Inc.'s Registration Statement on Form F-10 (File No. 333-280713).
What is the filing date of this Form 6-K?
This Form 6-K was filed on October 9, 2024.
Does this filing introduce new financial results for Cardiol Therapeutics Inc.?
No, this filing is administrative and incorporates an existing exhibit; it does not present new financial results.
What is the SEC file number for Cardiol Therapeutics Inc.?
The SEC file number for Cardiol Therapeutics Inc. is 001-40712.
Which registration statement is being supplemented by this filing?
The registration statement being supplemented is on Form F-10, with File No. 333-280713.
Filing Stats: 209 words · 1 min read · ~1 pages · Grade level 11.3 · Accepted 2024-10-09 14:17:07
Filing Documents
- tm2424074d6_6k.htm (6-K) — 11KB
- tm2424074d6_ex99-1.htm (EX-99.1) — 287KB
- tm2424074d6_ex99-2.htm (EX-99.2) — 10KB
- tm2424074d6_ex99-2img01.jpg (GRAPHIC) — 6KB
- tm2424074d6_ex99-2img02.jpg (GRAPHIC) — 1KB
- 0001104659-24-107298.txt ( ) — 320KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CARDIOL THERAPEUTICS INC. (Registrant) Date: October 9, 2024 By: /s/ Chris Waddick Name: Chris Waddick Title: Chief Financial Officer Form 6-K Exhibit Index Exhibit Number Document Description 99.1 Underwriting Agreement, dated October 9, 2024 99.2 News Release, dated October 9, 2024 – Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares